I‐Tsu Chyuan

1.0k total citations
27 papers, 741 citations indexed

About

I‐Tsu Chyuan is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, I‐Tsu Chyuan has authored 27 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Rheumatology. Recurrent topics in I‐Tsu Chyuan's work include Immune Cell Function and Interaction (9 papers), interferon and immune responses (5 papers) and Cell death mechanisms and regulation (5 papers). I‐Tsu Chyuan is often cited by papers focused on Immune Cell Function and Interaction (9 papers), interferon and immune responses (5 papers) and Cell death mechanisms and regulation (5 papers). I‐Tsu Chyuan collaborates with scholars based in Taiwan, Thailand and Japan. I‐Tsu Chyuan's co-authors include Ping‐Ning Hsu, Hong‐Tai Tzeng, Jenn‐Haung Lai, Hwei-Fang Tsai, Chien‐Sheng Wu, Ji-Yih Chen, Hsiu‐Jung Liao, Ching‐Liang Chu, Pei‐Jer Chen and Wei‐Yu Chen and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Frontiers in Immunology.

In The Last Decade

I‐Tsu Chyuan

25 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I‐Tsu Chyuan Taiwan 17 337 242 162 150 121 27 741
Lingxiao Xu China 19 283 0.8× 313 1.3× 261 1.6× 177 1.2× 102 0.8× 49 843
Saeed Aslani Iran 11 325 1.0× 206 0.9× 149 0.9× 181 1.2× 63 0.5× 23 737
Jongkonnee Wongpiyabovorn Thailand 18 398 1.2× 208 0.9× 187 1.2× 113 0.8× 62 0.5× 58 828
Elham Farhadi Iran 19 358 1.1× 326 1.3× 352 2.2× 123 0.8× 80 0.7× 95 1.1k
Qianjin Lu China 16 393 1.2× 308 1.3× 344 2.1× 112 0.7× 72 0.6× 44 908
Lina Tan China 14 181 0.5× 289 1.2× 126 0.8× 51 0.3× 71 0.6× 31 650
Lino L. Teichmann Germany 10 675 2.0× 216 0.9× 199 1.2× 230 1.5× 54 0.4× 26 1.2k
Asmaa Gaber Abdou Egypt 17 212 0.6× 244 1.0× 65 0.4× 165 1.1× 66 0.5× 101 907
Andrew Cross United Kingdom 12 494 1.5× 334 1.4× 107 0.7× 148 1.0× 77 0.6× 22 824
Weiwei Chen China 14 558 1.7× 221 0.9× 39 0.2× 114 0.8× 149 1.2× 45 890

Countries citing papers authored by I‐Tsu Chyuan

Since Specialization
Citations

This map shows the geographic impact of I‐Tsu Chyuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Tsu Chyuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Tsu Chyuan more than expected).

Fields of papers citing papers by I‐Tsu Chyuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Tsu Chyuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Tsu Chyuan. The network helps show where I‐Tsu Chyuan may publish in the future.

Co-authorship network of co-authors of I‐Tsu Chyuan

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Tsu Chyuan. A scholar is included among the top collaborators of I‐Tsu Chyuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Tsu Chyuan. I‐Tsu Chyuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chien‐Sheng, Feng‐Cheng Liu, Shih‐Chang Lin, & I‐Tsu Chyuan. (2025). Regulation of T cell receptor (TCR) signaling by tyrosine phosphatases: Recent advances and implication for therapeutic approach in autoimmune diseases. Journal of the Formosan Medical Association.
2.
Liao, Hsiu‐Jung, et al.. (2025). Interleukin 27 (IL-27) productions in the liver microenvironment confer an immunosuppressive role and enhance hepatitis B viral persistence. Journal of Microbiology Immunology and Infection. 59(2). 172–180.
3.
Chyuan, I‐Tsu, Hsiu‐Jung Liao, Tse‐Hua Tan, et al.. (2024). Association of TRAIL receptor with phosphatase SHP-1 enables repressing T cell receptor signaling and T cell activation through inactivating Lck. Journal of Biomedical Science. 31(1). 33–33. 5 indexed citations
4.
Chyuan, I‐Tsu, Ching‐Liang Chu, & Ping‐Ning Hsu. (2021). Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies. Cancers. 13(6). 1188–1188. 46 indexed citations
5.
Tzeng, Hong‐Tai, I‐Tsu Chyuan, & Jenn‐Haung Lai. (2021). Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential. Biochemical Pharmacology. 193. 114760–114760. 58 indexed citations
6.
Tzeng, Hong‐Tai & I‐Tsu Chyuan. (2021). Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications. Journal of the Formosan Medical Association. 120(9). 1667–1675. 13 indexed citations
7.
Chyuan, I‐Tsu, et al.. (2020). Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus. Cellular and Molecular Immunology. 18(7). 1772–1782. 16 indexed citations
8.
Chyuan, I‐Tsu & Jenn‐Haung Lai. (2020). New insights into the IL-12 and IL-23: From a molecular basis to clinical application in immune-mediated inflammation and cancers. Biochemical Pharmacology. 175. 113928–113928. 69 indexed citations
9.
Liao, Hsiu‐Jung, Hwei-Fang Tsai, Chien‐Sheng Wu, I‐Tsu Chyuan, & Ping‐Ning Hsu. (2019). TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment. Cell Death and Disease. 10(2). 77–77. 32 indexed citations
10.
Tzeng, Hong‐Tai, I‐Tsu Chyuan, & Wei‐Yu Chen. (2019). Shaping of Innate Immune Response by Fatty Acid Metabolite Palmitate. Cells. 8(12). 1633–1633. 36 indexed citations
11.
Chyuan, I‐Tsu, et al.. (2019). TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway. Mucosal Immunology. 12(4). 980–989. 24 indexed citations
12.
Chyuan, I‐Tsu, et al.. (2019). Lovastatin‐mediated MCF‐7 cancer cell death involves LKB1‐AMPK‐p38MAPK‐p53‐survivin signalling cascade. Journal of Cellular and Molecular Medicine. 24(2). 1822–1836. 49 indexed citations
13.
14.
Wang, Chen‐Ying, I‐Tsu Chyuan, Yu‐Kang Tu, et al.. (2017). Significant association of rheumatoid arthritis-related inflammatory markers with non-surgical periodontal therapy. Journal of the Formosan Medical Association. 117(11). 1003–1010. 16 indexed citations
15.
Chyuan, I‐Tsu, Hwei-Fang Tsai, Hsiu‐Jung Liao, Chien‐Sheng Wu, & Ping‐Ning Hsu. (2017). An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis. Cellular and Molecular Immunology. 15(9). 846–857. 33 indexed citations
16.
Liao, Hsiu‐Jung, I‐Tsu Chyuan, Chien‐Sheng Wu, et al.. (2015). Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Lara D. Veeken. 54(7). 1317–1326. 25 indexed citations
17.
Chyuan, I‐Tsu, et al.. (2015). Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model. Cellular and Molecular Immunology. 12(3). 317–325. 25 indexed citations
18.
Tsai, Hwei-Fang, et al.. (2015). Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis. Journal of Molecular Medicine. 94(5). 545–556. 39 indexed citations
19.
Tsai, Hwei-Fang, I‐Tsu Chyuan, Hsiu‐Jung Liao, et al.. (2014). Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model. PLoS ONE. 9(7). e103008–e103008. 52 indexed citations
20.
Wu, Chien‐Sheng, Chung‐Yi Hu, Hwei-Fang Tsai, et al.. (2013). Elevated serum level of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus patients is associated with nephritis and cutaneous vasculitis. Rheumatology International. 34(5). 625–629. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingxiao Xu Breakdown of academic impact, for papers by Saeed Aslani Breakdown of academic impact, for papers by Jongkonnee Wongpiyabovorn Breakdown of academic impact, for papers by Elham Farhadi Breakdown of academic impact, for papers by Qianjin Lu Breakdown of academic impact, for papers by Lina Tan Breakdown of academic impact, for papers by Lino L. Teichmann Breakdown of academic impact, for papers by Asmaa Gaber Abdou Breakdown of academic impact, for papers by Andrew Cross Breakdown of academic impact, for papers by Weiwei Chen
Rankless by CCL
2026